Your shopping cart is currently empty

SR13668 is a potent indole analog derived from indole-3-methanol (I3C), renowned for its natural anti-cancer properties but limited by poor metabolic characteristics. Designed to enhance the anti-cancer efficacy of I3C, SR13668 effectively inhibits Akt activation stimulated by growth factors. It exhibits strong oral anti-cancer activity across various cancer types, demonstrating both high safety and robust inhibitory effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,820 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,380 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,100 | 10-14 weeks | 10-14 weeks |
| Description | SR13668 is a potent indole analog derived from indole-3-methanol (I3C), renowned for its natural anti-cancer properties but limited by poor metabolic characteristics. Designed to enhance the anti-cancer efficacy of I3C, SR13668 effectively inhibits Akt activation stimulated by growth factors. It exhibits strong oral anti-cancer activity across various cancer types, demonstrating both high safety and robust inhibitory effects. |
| Molecular Weight | 430.45 |
| Formula | C25H22N2O5 |
| Cas No. | 637774-61-9 |
| Smiles | O=C(OCC)C1=CC=C2NC=3C(OC)=C4NC=5C=CC(=CC5C4=CC3C2=C1)C(=O)OCC |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.